Business
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
SAN FRANCISCO, May 18, 2026--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $300 million aggregate principal amount of convertible senior notes due 2032 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hims & Hers also expects to grant the initial pur
About this update from Hims & Hers Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2562,"height":408,"url":"https://media.zenfs.com/en/business-wire.com/b40388685c8c685be0b60a27f7b2ad13"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ZXnPjU2VHAFFXbyYOOgPHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1Mw--/https://media.zenfs.com/en/business-wire.com/b40388685c8c685be0b60a27f7b2ad13","width":960,"height":153},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/XRymvLpTZHwvVm0Cb1xwjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEwMg--/https://media.zenfs.com/en/business-wire.com/b40388685c8c685be0b60a27f7b2ad13","width":640,"height":102},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/1jST51jzlqzm9be3gLJotA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zODI-/https://media.zenfs.com/en/business-wire.com/b40388685c8c685be0b60a27f7b2ad13","width":1200,"height":191}},"lazy":false},{"type":"text","content":"Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its international expansion strategy, including the proposed acquisition of Eucalyptus, invests in technology and operational infrastructure to drive anticipated cost efficiencies, and enhances the consumer experience with AI and its closed-loop data ecosystem.","length":355,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, May 18, 2026--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its intention to offer, subject to market and other conditions, $300 million aggregate principal amount of convertible senior notes due 2032 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Hims & Hers also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $45 million aggregate principal amount of notes.","length":781,"tagName":"p"},{"type":"text","content":"Hims & Hers intends to use the net proceeds from the offering to preserve financial flexibility while executing on its international expansion strategy, including its pr...